DAX futures drop following bullish session on Wednesday

Futures markets suggest the German DAX will open lower on Thursday, following a strong session across global equity markets overnight.

DAX futures in focus

Key European markets rallied firmly overnight – as the prospect of a potential Covid-19 vaccine looks to have sparked a new wave of investor optimism.

Specifically, the DAX rose an impressive 1.84% to finish the session at the 12,930 point level; the British FTSE 100 added 1.83%; the French CAC climbed 101 points; and the Italian FTSE MIB added 2.02% to close above the 20,000 point level.

Examining the German benchmark’s performance from a technical perspective – IG’s Chief Market Analyst, Chris Beauchamp, argued that the gains witnessed on Wednesday ‘are likely to continue unless a reversal below 12,400 develops. Further gains target 12,954 and then on to 13,600.’

On a more granular level, the best performing German stocks on Wednesday were MTU Aero Engines (+7.02%), Linde (+4.15%) and Merck (+3.79%); while the worst performing were Bayer, Continental, and Wirecard.

Wirecard continues to struggle

Wirecard (WDI) in particular has traded with pronounced volatility over the last month – with its market value plunging ~97% in that period after the company revealed that it could not locate some €1.9 billion in cash – representing approximately one quarter of the firm’s balance sheet.

Wirecard would soon declare that the ‘prevailing likelihood’ was that the cash never existed to begin with. In spite of this, investors continue to trade the stock – with WDI finishing out Wednesday’s session at €2.21 per share. For reference, in September 2018, Wirecard traded close to €200 per share.

Looking forward, as of 2:21AM (Berlin time), DAX futures were trading down 75.2 points or 0.58%, suggesting that the blue-chip German benchmark would open lower on Thursday, 16 July.

Elsewhere, US markets also traded strongly overnight, with the Dow Jones Industrial Average rising 227 points, the S&P 500 gained 29 points and the Nasdaq Composite added 61 points.

Despite this, US futures were also trading lower at the time of writing.

Catalysts in focus

Looking at the fundamental drivers behind global equity market’s bullish price action overnight, IG’s market analyst, Kyle Rodda argued that ‘Positive developments in the pursuit for a COVID-19 vaccine once again outweighed concerns about the worsening of the pandemic yesterday.’

Positive developments or not, cases of the virus continue to tick higher on a global scale, last standing at 13.67 million reported cases.

Regardless of these growing case counts, Mr Rodda went on to note that it appears that the ‘Threat posed by the virus and the risk of potential new lockdowns [is being] overlooked, as market sentiment found itself juiced by separate announcements from US biotech company Moderna, and the University of Oxford, that progress is being made in their respective efforts to develop a COVID-19 vaccine.’

The Moderna share price finished out the session up 6.90% at US$80.22 per share.

Want to trade local and international markets: long or short?

Create an IG trading account or log in to your existing account to get started now.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.


Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.